“It looks like it’s going to shake out in the 400bp area,” said a banker close to the transaction.
The US wound therapy company was looking to reduce the rate on its euro term loan ‘B’ from 425bp and decrease the Euribor floor from 1.50% to 1.25%.
Convatec (B+/B2) ...Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: subs@globalcapital.com
Corporate access
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.
